Associations between polygenic risk of coronary artery disease and type 2 diabetes, lifestyle, and cardiovascular mortality: A prospective UK Biobank study

被引:6
作者
Yun, Jae-Seung [1 ,2 ]
Jung, Sang-Hyuk [1 ,3 ,4 ]
Shivakumar, Manu [1 ,4 ,5 ]
Xiao, Brenda [1 ,5 ]
Khera, Amit V. [6 ]
Park, Woong-Yang [7 ]
Won, Hong-Hee [3 ,7 ]
Kim, Dokyoon [1 ,4 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA
[2] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Internal Med,Div Endocrinol & Metab, Division of Endocrinolog, Seoul, South Korea
[3] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol SAIHST, Samsung Med Ctr, Seoul, South Korea
[4] Univ Penn, Inst Biomed Informat, Philadelphia, PA 19104 USA
[5] Univ Penn, Genom & Computat Biol Grad Grp, Philadelphia, PA USA
[6] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA USA
[7] Sungkyunkwan Univ, Samsung Genome Inst, Samsung Med Ctr, Sch Med, Seoul, South Korea
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
基金
新加坡国家研究基金会;
关键词
polygenic risk score; lifestyle; cardiovascular mortality; coronary artery disease; type 2 diabetes mellitus; GENOME-WIDE ASSOCIATION; GENETIC RISK; HEART-DISEASE; SCORES; PREDICTION; UTILITY; EVENTS; IMPACT;
D O I
10.3389/fcvm.2022.919374
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundPrevious studies primarily targeted the ability of polygenic risk scores (PRSs) to predict a specific disease, and only a few studies have investigated the association between genetic risk scores and cardiovascular (CV) mortality. We assessed PRSs for coronary artery disease (CAD) and type 2 diabetes (T2DM) as the predictive factors for CV mortality, independent of traditional risk factors, and further investigated the additive effect between lifestyle behavior and PRS on CV mortality. MethodsWe used genetic and phenotypic data from UK Biobank participants aged 40-69 years at baseline, collected with standardized procedures. Genome-wide PRSs were constructed using >6 million genetic variants. Cox proportional hazard models were used to analyze the relationship between PRS and CV mortality with stratification by age, sex, disease status, and lifestyle behavior. ResultsOf 377,909 UK Biobank participants having European ancestry, 3,210 (0.8%) died due to CV disease during a median follow-up of 8.9 years. CV mortality risk was significantly associated with CAD PRS [low vs. very high genetic risk groups, CAD PRS hazard ratio (HR) 2.61 (2.02-3.36)] and T2DM PRS [HR 2.08 (1.58-2.73)], respectively. These relationships remained significant even after an adjustment for a comprehensive range of demographic and clinical factors. In the very high genetic risk group, adherence to an unfavorable lifestyle was further associated with a substantially increased risk of CV mortality [favorable vs. unfavorable lifestyle with very high genetic risk for CAD PRS, HR 8.31 (5.12-13.49); T2DM PRS, HR 5.84 (3.39-10.04)]. Across all genetic risk groups, 32.1% of CV mortality was attributable to lifestyle behavior [population attributable fraction (PAF) 32.1% (95% CI 28.8-35.3%)] and 14.1% was attributable to smoking [PAF 14.1% (95% CI 12.4-15.7%)]. There was no evidence of significant interaction between PRSs and age, sex, or lifestyle behavior in predicting the risk of CV mortality. ConclusionPRSs for CAD or T2DM and lifestyle behaviors are the independent predictive factors for future CV mortality in the white, middle-aged population. PRS-based risk assessment could be useful to identify the individuals who need intensive behavioral or therapeutic interventions to reduce the risk of CV mortality.
引用
收藏
页数:11
相关论文
共 33 条
  • [1] The Charlson Comorbidity Index in Registry-based Research Which Version to Use?
    Brusselaers, Nele
    Lagergren, Jesper
    [J]. METHODS OF INFORMATION IN MEDICINE, 2017, 56 (05) : 401 - 406
  • [2] The UK Biobank resource with deep phenotyping and genomic data
    Bycroft, Clare
    Freeman, Colin
    Petkova, Desislava
    Band, Gavin
    Elliott, Lloyd T.
    Sharp, Kevin
    Motyer, Allan
    Vukcevic, Damjan
    Delaneau, Olivier
    O'Connell, Jared
    Cortes, Adrian
    Welsh, Samantha
    Young, Alan
    Effingham, Mark
    McVean, Gil
    Leslie, Stephen
    Allen, Naomi
    Donnelly, Peter
    Marchini, Jonathan
    [J]. NATURE, 2018, 562 (7726) : 203 - +
  • [3] Genetic Risk Score Associations With Cardiovascular Disease and Mortality in the Diabetes Heart Study
    Cox, Amanda J.
    Hsu, Fang-Chi
    Ng, Maggie C. Y.
    Langefeld, Carl D.
    Freedman, Barry I.
    Carr, J. Jeffrey
    Bowden, Donald W.
    [J]. DIABETES CARE, 2014, 37 (04) : 1157 - 1164
  • [4] Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial
    Damask, Amy
    Steg, P. Gabriel
    Schwartz, Gregory G.
    Szarek, Michael
    Hagstroem, Emil
    Badimon, Lina
    Chapman, M. John
    Boileau, Catherine
    Tsimikas, Sotirios
    Ginsberg, Henry N.
    Banerjee, Poulabi
    Manvelian, Garen
    Pordy, Robert
    Hess, Sibylle
    Overton, John D.
    Lotta, Luca A.
    Yancopoulos, George D.
    Abecasis, Goncalo R.
    Baras, Aris
    Paulding, Charles
    [J]. CIRCULATION, 2020, 141 (08) : 624 - 636
  • [5] The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine
    Elliott, Paul
    Peakman, Tim C.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2008, 37 (02) : 234 - 244
  • [6] Genetic Predisposition to Type 2 Diabetes and Risk of Subclinical Atherosclerosis and Cardiovascular Diseases Among 160,000 Chinese Adults
    Gan, Wei
    Bragg, Fiona
    Walters, Robin G.
    Millwood, Iona Y.
    Lin, Kuang
    Chen, Yiping
    Guo, Yu
    Vaucher, Julien
    Bian, Zheng
    Bennett, Derrick
    Lv, Jun
    Yu, Canqing
    Mahajan, Anubha
    Clarke, Robert J.
    Li, Liming
    Holmes, Michael V.
    McCarthy, Mark I.
    Chen, Zhengming
    [J]. DIABETES, 2019, 68 (11) : 2155 - 2164
  • [7] 5 year mortality predictors in 498 103 UK Biobank participants: a prospective population-based study
    Ganna, Andrea
    Ingelsson, Erik
    [J]. LANCET, 2015, 386 (9993) : 533 - 540
  • [8] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    Haffner, SM
    Lehto, S
    Rönnemaa, T
    Pyörälä, K
    Laakso, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) : 229 - 234
  • [9] Genetic Risk, a Healthy Lifestyle, and Type 2 Diabetes: the Dongfeng-Tongji Cohort Study
    Han, Xu
    Wei, Yue
    Hu, Hua
    Wang, Jing
    Li, Zhaoyang
    Wang, Fei
    Long, Tengfei
    Yuan, Jing
    Yao, Ping
    Wei, Sheng
    Wang, Youjie
    Zhang, Xiaomin
    Guo, Huan
    Yang, Handong
    Wu, Tangchun
    He, Meian
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (04) : 1242 - 1250
  • [10] A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
    Howie, Bryan N.
    Donnelly, Peter
    Marchini, Jonathan
    [J]. PLOS GENETICS, 2009, 5 (06)